Market Overview:
The Global In-pipe Inspection Robot Market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for in-pipe inspection robots from non-profit institutions, hospitals and clinics. North America is expected to dominate the market during the forecast period owing to the presence of key players in this region. Asia Pacific is projected to be the fastest growing region during the forecast period owing to rising investments by key players in this region.
Product Definition:
An in-pipe inspection robot is a device that is inserted into a pipe for the purpose of inspecting the pipe's interior. The robot typically has a camera and other sensors that allow it to send back images and data about the condition of the pipe. This data can be used to help identify problems with the pipe and determine what actions need to be taken in order to address them.
Polyvalent Anti-Venom:
Polyvalent anti-venom is a new term in the field of robotics and mechatronics. It was first used by Dr. Robert Dickinson, an American biopharmaceutical engineer to describe antibodies that can bind themselves to several targets such as enzymes, cells or molecules. The most important property of polyvalent antibody is its binding affinity for more than one antigenic determinant on the same epitope (the site where the immune response is directed).
Monovalent Anti-Venom:
Monovalent anti-venom is a new term in the field of robotics and automation. It means that only one type of input device is required for the robot to move around. In other words, it has a single sensor or one motor for its movement. Monovalent robots can be programmed to perform specific tasks by using built-in software algorithms without any human intervention.
In recent years, there have been significant developments in Artificial Intelligence (AI).
Application Insights:
The global in-pipe inspection robot market is segmented by application into non-profit institutions, hospitals and clinics, and other healthcare facilities. The non-profit institutions segment dominated the overall industry in terms of revenue share in 2017. This can be attributed to factors such as high usage rates of anti-venom pumps at hospitals globally. Furthermore, this segment is expected to maintain its dominance over the forecast period due to increasing investments by governments worldwide for building new healthcare facilities or upgrading existing ones which include venipuncture machines and anti-venom systems.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major players, such as Becton; Dickinson and Company; Johnson & Johnson Services, Inc.; and Merck Group. The increasing incidence of snakebite injuries coupled with rising demand for anti-venom is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing medical tourism industry, increase in healthcare expenditure by governments along with an increase in demand for quality healthcare services resulting from a rise in prevalence of chronic diseases. Moreover, increasing investments by public and private entities are likely to boost revenue generation through product sales. For instance, Dr Reddy's Laboratories Ltd., India based pharmaceutical company has developed a low-cost In-pipe Inspection Robot (IPIR) that can be used during surgeries or other procedures requiring detailed inspection of pipes/wires/surgical instruments etc.
Growth Factors:
- Increasing demand for in-pipe inspection robots from the oil and gas industry as a result of the increasing exploration and production activities across the globe.
- Rising demand for in-pipe inspection robots from municipal water and wastewater treatment plants due to stringent government regulations on water quality and safety.
- Growing popularity of in-pipe inspection robots among pipeline operators due to their ability to detect defects, leaks, and other anomalies in pipelines without having to shut down the pipeline operations.
- Proliferation of smart grid infrastructure that is expected to create new opportunities for deployment of in-pipe inspection robots for condition monitoring of energy pipelines.
Scope Of The Report
Report Attributes
Report Details
Report Title
In-pipe Inspection Robot Market Research Report
By Type
Polyvalent Anti-Venom, Monovalent Anti-Venom
By Application
Non-profit Institutions, Hospitals and Clinic
By Companies
CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global In-pipe Inspection Robot Market Report Segments:
The global In-pipe Inspection Robot market is segmented on the basis of:
Types
Polyvalent Anti-Venom, Monovalent Anti-Venom
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Non-profit Institutions, Hospitals and Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL
- Merck
- BTG
- Pfizer
- Haffkine Bio-Pharmaceutical
- Rare Disease Therapeutics
- Flynn Pharma
- Vins Bioproducts
- Bharat Serums and Vaccines
- Serum Biotech
- MicroPharm
Highlights of The In-pipe Inspection Robot Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyvalent Anti-Venom
- Monovalent Anti-Venom
- By Application:
- Non-profit Institutions
- Hospitals and Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In-pipe Inspection Robot Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In-pipe inspection robot is a type of inspection robot that uses an endoscope to inspect pipes and other tubes.
Some of the major players in the in-pipe inspection robot market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In-pipe Inspection Robot Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In-pipe Inspection Robot Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In-pipe Inspection Robot Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In-pipe Inspection Robot Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In-pipe Inspection Robot Market Size & Forecast, 2020-2028
4.5.1 In-pipe Inspection Robot Market Size and Y-o-Y Growth
4.5.2 In-pipe Inspection Robot Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polyvalent Anti-Venom
5.2.2 Monovalent Anti-Venom
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Non-profit Institutions
6.2.2 Hospitals and Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In-pipe Inspection Robot Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In-pipe Inspection Robot Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polyvalent Anti-Venom
9.6.2 Monovalent Anti-Venom
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Non-profit Institutions
9.10.2 Hospitals and Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polyvalent Anti-Venom
10.6.2 Monovalent Anti-Venom
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Non-profit Institutions
10.10.2 Hospitals and Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polyvalent Anti-Venom
11.6.2 Monovalent Anti-Venom
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Non-profit Institutions
11.10.2 Hospitals and Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polyvalent Anti-Venom
12.6.2 Monovalent Anti-Venom
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Non-profit Institutions
12.10.2 Hospitals and Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polyvalent Anti-Venom
13.6.2 Monovalent Anti-Venom
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Non-profit Institutions
13.10.2 Hospitals and Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In-pipe Inspection Robot Market: Competitive Dashboard
14.2 Global In-pipe Inspection Robot Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CSL
14.3.2 Merck
14.3.3 BTG
14.3.4 Pfizer
14.3.5 Haffkine Bio-Pharmaceutical
14.3.6 Rare Disease Therapeutics
14.3.7 Flynn Pharma
14.3.8 Vins Bioproducts
14.3.9 Bharat Serums and Vaccines
14.3.10 Serum Biotech
14.3.11 MicroPharm
